Sign In
Buy VERV
$11.13
+0 (+0%)
At Close: Oct 24, 2025
Verve Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
06:30am, Monday, 27'th Sep 2021
CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, to
Verve Therapeutics' Gene-Editing Therapy Shows Encouraging Preclinical Action In Cardiovascular Disease
11:03am, Thursday, 23'rd Sep 2021
Verve Therapeutics Inc (NASDAQ: VERV) has reported new preclinical data from 36 non-human primates (NHPs) with its lead candidate, VERVE-101. VERVE-101 is a potential single-course gene-editing tre
Verve Therapeutics: Pioneering Cardiovascular Medicine Using The Power Of Gene Editing
03:37pm, Tuesday, 24'th Aug 2021
Verve is a new IPO formed by world experts in cardiology and genetics.
Verve Therapeutics Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results
06:30am, Thursday, 12'th Aug 2021
New Preclinical Base Editing Durability Data and Proprietary GalNAc-targeted Lipid Nanoparticle Delivery Technology Data to be Presented at TIDES in September 2021
Ignoring Monday's 2 Big Nasdaq Winners Could Cost You Serious Money
01:17pm, Monday, 28'th Jun 2021
Find out why these stocks are climbing higher.
Verve Therapeutics shares soar 68% in trading debut
12:47pm, Thursday, 17'th Jun 2021
Verve Therapeutics Inc. shares soared 68% in their trading debut Thursday, after the Massachusetts-based biotechnology company's upsized initial public offering priced above the expected range to valu
3 Biotechs Plus a Mortgage Lender Go Public Today
12:36pm, Thursday, 17'th Jun 2021
The companies are Verve Therapeutics, Lyell Immunopharma, iSpecimen and Angel Oak Mortgage.
Verve Therapeutics upsized IPO prices above the expected range
06:14am, Thursday, 17'th Jun 2021
Verve Therapeutics Inc. is set to go public Thursday, after the Massachusetts-based biotechnology company's upsized initial public offering priced overnight above the expected range to value the compa
Verve Therapeutics Announces Pricing of Initial Public Offering
09:24pm, Wednesday, 16'th Jun 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the
